Survival benefit and additional value of preoperative chemoradiotherapy in resectable gastric and gastro-oesophageal junction cancer: A direct and adjusted indirect comparison meta-analysis

European Journal of Surgical Oncology

Volumn 41, Issue 3, 2015, Pages 282-294

  Kumagai, K ^a   Rouvelas, I ^a   Tsai, J A ^a   Mariosa, D ^b   Lind, P A ^b,c   Lindblad, M ^a   Ye, W ^b   Lundell, L ^a   Schuhmacher, C ^d   Mauer, M ^e   Burmeister, B H ^f   Thomas, J M ^f   Stahl, M ^g   Nilsson, M ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e EORTC DATA CENTER   (Belgium)

^f UNIVERSITY OF QUEENSLAND   (Australia)

^g KLINIKEN ESSEN MITTE   (Germany)

Author keywords

Adenocarcinoma; Gastro oesophageal junction; Preoperative chemoradiotherapy; Preoperative chemotherapy; Stomach

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; FOLINIC ACID; METHOTREXATE; PACLITAXEL; VINBLASTINE;

AREA UNDER THE CURVE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; COMPARATIVE STUDY; ESOPHAGUS CANCER; HAZARD RATIO; HUMAN; LOWER ESOPHAGUS SPHINCTER; META ANALYSIS; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PATIENT CODING; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE FRACTIONATION; REVIEW; STOMACH CANCER; SYSTEMATIC REVIEW; ADENOCARCINOMA; ADJUVANT CHEMORADIOTHERAPY; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; DISEASE FREE SURVIVAL; ESOPHAGUS RESECTION; GASTRECTOMY; MORTALITY; PROCEDURES; STOMACH NEOPLASMS; SURGERY; TREATMENT OUTCOME;

ADENOCARCINOMA; CHEMORADIOTHERAPY, ADJUVANT; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; ESOPHAGECTOMY; ESOPHAGOGASTRIC JUNCTION; GASTRECTOMY; HUMANS; NEOADJUVANT THERAPY; RADIOTHERAPY, ADJUVANT; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 84923065603     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2014.11.039     Document Type: Review

References (37)

1. R.T. Greenlee, T. Murray, S. Bolden, and P.A. Wingo Cancer statistics, 2000 CA Cancer J Clin 50 1 2000 7
2. U. Ronellenfitsch, M. Schwarzbach, and R. Hofheinz Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: systematic review with meta-analysis combining individual patient and aggregate data Eur J Cancer 49 15 2013 3149
3. F. Fiorica, F. Cartei, and M. Enea The impact of radiotherapy on survival in resectable gastric carcinoma: a meta-analysis of literature data Cancer Treat Rev 33 8 2007 729
4. J.A. Ajani, P.F. Mansfield, and N. Janjan Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma J Clin Oncol 22 14 2004 2774
5. J.A. Ajani, P.F. Mansfield, and C.H. Crane Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome J Clin Oncol 23 6 2005 1237
6. J.A. Ajani, K. Winter, and G.S. Okawara Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response J Clin Oncol 24 24 2006 3953
7. M. Stahl, M.K. Walz, and M. Stuschke Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction J Clin Oncol 27 6 2009 851
8. F. Song, Y.K. Loke, T. Walsh, A.M. Glenny, A.J. Eastwood, and D.G. Altman Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews BMJ 338 2009 b1147
9. A.R. Jadad, R.A. Moore, and D. Carroll Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1 1996 1
10. M.K. Parmar, V. Torri, and L. Stewart Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints Stat Med 17 24 1998 2815
11. C. Bassi, C. Dervenis, and G. Butturini Postoperative pancreatic fistula: an international study group (ISGPF) definition Surgery 138 1 2005 8
12. D. Moher, A. Liberati, J. Tetzlaff, and D.G. Altman Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement BMJ 339 2009 b2535
13. A.M. Glenny, D.G. Altman, and F. Song Indirect comparisons of competing interventions Health Technol Assess 9 26 2005 1
14. C.B. Begg, and M. Mazumdar Operating characteristics of a rank correlation test for publication bias Biometrics 50 4 1994 1088
15. W.H. Allum, S.P. Stenning, J. Bancewicz, P.I. Clark, and R.E. Langley Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer J Clin Oncol 27 30 2009 5062
16. B.H. Burmeister, J.M. Thomas, and E.A. Burmeister Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial Eur J Cancer 47 3 2011 354
17. D. Cunningham, W.H. Allum, and S.P. Stenning Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med 355 1 2006 11
18. H.H. Hartgrink, C.J. Van de Velde, and H. Putter Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial Eur J Surg Oncol 30 6 2004 643
19. D.P. Kelsen, K.A. Winter, and L.L. Gunderson Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer J Clin Oncol 25 24 2007 3719
20. C. Schuhmacher, S. Gretschel, and F. Lordick Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954 J Clin Oncol 28 35 2010 5210
21. I.B. Shchepotin, S.R. Evans, and V. Chorny Intensive preoperative radiotherapy with local hyperthermia for the treatment of gastric carcinoma Surg Oncol 3 1 1994 37
22. V. Skoropad, B. Berdov, and V. Zagrebin Concentrated preoperative radiotherapy for resectable gastric cancer: 20-years follow-up of a randomized trial J Surg Oncol 80 2 2002 72
23. V.Y. Skoropad, B.A. Berdov, Y.S. Mardynski, and L.N. Titova A prospective, randomized trial of pre-operative and intraoperative radiotherapy versus surgery alone in resectable gastric cancer Eur J Surg Oncol 26 8 2000 773
24. J. Tepper, M.J. Krasna, and D. Niedzwiecki Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781 J Clin Oncol 26 7 2008 1086
25. S.G. Urba, M.B. Orringer, A. Turrisi, M. Iannettoni, A. Forastiere, and M. Strawderman Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma J Clin Oncol 19 2 2001 305
26. P. van Hagen, M.C. Hulshof, and J.J. van Lanschot Preoperative chemoradiotherapy for esophageal or junctional cancer N Engl J Med 366 22 2012 2074
27. T.N. Walsh, M. Grennell, S. Mansoor, and A. Kelly Neoadjuvant treatment of advanced stage esophageal adenocarcinoma increases survival Dis Esophagus 15 2 2002 121
28. X.L. Wang, G.X. Wu, M.D. Zhang, M. Guo, H. Zhang, and X.F. Sun A favorable impact of preoperative FPLC chemotherapy on patients with gastric cardia cancer Oncol Rep 7 2 2000 241
29. M. Ychou, V. Boige, and J.P. Pignon Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial J Clin Oncol 29 13 2011 1715
30. Z.X. Zhang, X.Z. Gu, W.B. Yin, G.J. Huang, D.W. Zhang, and R.G. Zhang Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of gastric cardia (AGC) - report on 370 patients Int J Radiat Oncol Biol Phys 42 5 1998 929
31. W.H. Zhao, S.F. Wang, and W. Ding Apoptosis induced by preoperative oral 5′-DFUR administration in gastric adenocarcinoma and its mechanism of action World J Gastroenterol 12 9 2006 1356
32. D.P. Kelsen, R. Ginsberg, and T.F. Pajak Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer N Engl J Med 339 27 1998 1979
33. K. Kumagai, I. Rouvelas, and J.A. Tsai Meta-analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro-oesophageal junctional cancers Br J Surg 101 4 2014 321
34. J.S. Macdonald, S.R. Smalley, and J. Benedetti Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal Junction N Engl J Med 345 10 2001 725
35. S. Sakuramoto, M. Sasako, and T. Yamaguchi Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine N Engl J Med 357 18 2007 1810
36. Y.J. Bang, Y.W. Kim, and H.K. Yang Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial Lancet 379 9813 2012 315
37. J.J. Bonenkamp, J. Hermans, and M. Sasako Extended lymph-node dissection for gastric cancer N Engl J Med 340 12 1999 908